Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Technique for decellularization and characterization of rat esophageal extracellular matrix for potential application as a 3D scaffold

Mathur V., Joshi JM., N C S., N Seetharam R., Vasanthan KS.

Animal Study on Autoimmune Research, published in Bioengineered (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Bioengineered (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40990065
PMCID
PMC12461892
DOI
10.1080/21655979.2025.2564563

Abstract (original English)

Conventional treatment for esophageal defects involves surgical removal of the defect area and implant conduit tissues. There exist morbidities and mortalities associated with the treatment including fistula and leakage leading to compromise in quality of life. The aim of this study was to optimize a method for complete decellularization of rat esophagus and to solubilize the decellularized extracellular matrix (dECM) proteins to evaluate in vitro properties for scaffold fabrication. For decellularization, rat esophagi were decellularized using 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) and sodium dodecyl sulfate (SDS) buffers for 6 h and overnight, respectively. Post decellularization, the tissue was characterized for DNA, glycosaminoglycans, and elastin quantification; H&E and Masson's trichrome staining; scanning electron microscopy; and SDS-PAGE to evaluate the quantity and quality of the obtained dECM. DNA quantification and histological analysis revealed complete decellularization, while the retention of sGAGs and elastin showed the presence of extracellular proteins in the tissue. The SEM analysis revealed proper orientation of the extracellular matrix and significant proteins were retained in the dECM, which will enhance the regenerative potential. The decellularized tissues were biocompatible, exhibited no toxicity and were also soluble, which c

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
EsophagusExtracellular MatrixAnimalsRatsElastinTissue EngineeringMaleTissue ScaffoldsDecellularized Extracellular Matrix

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research